SEC Form 4 · accession 0001179110-16-027019
ENDOCYTE INC · ECYT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
P Ron Ellis
Other
Period of report
Jun 24, 2016
Accepted (ET)
Jun 28, 2016 · 5:07 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001235007
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Jun 24, 2016 | F | 13,528 | $3.68 | D | 320,040 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares withheld to satisfy tax withholding obligations associated with the settlement of 42,603 restricted stock units in the form of Company common stock on a one-for-one basis on June 24, 2016.
- F2Includes 2,617 shares acquired under the Endocyte, Inc. 2010 Employee Stock Purchase Plan on June 15, 2016.